Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates

By AiT Analyst On Jul 25, 2022

This is our AI Daily Roundup today. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and human-system interactions. We cover the role of AI Daily Roundup and its application in various industries and daily lives.

AI Adoption Could Save Businesses $35,000 Every Year

Businesses are immensely benefiting from AI adoption. AI technologies and capabilities have enabled businesses to transform their operations and scope of revenue generation with an unmatched precision. In 2022, the global AI software industry will touch $62 billion, thanks to an enhanced adoption rate among businesses that see AI and other intelligent capabilities as a means to mature in changing economic landscape. A new report from Yell highlights on the growing potential of using AI in business. It has revealed the impressive time, money and effort savings companies around the world could stand to make with AI adoption. If done right, businesses can s********* $35000* every year– an absolute game-changer in the modern context of automation and financial stability.

From Innovation to Infiltration: The New Cyber Threat Landscape

Nov 22, 2024

AI Superintelligence: Breakthrough or Buzzword?

Nov 22, 2024

Lightning AI Raises $50Million to Simplify and Scale AI Development For Enterprises and Developers

Nov 22, 2024

Prev Next 1 of 41,148

AiThority.com to Attend The Character of AI – A Technology Ethics Conference (Virtual)

AiThority.com, a leading B2B Technology publication dedicated to emerging domains in AI, Cloud Computing, Data Science and IoT, will be attending the The Character of AI – A Technology Ethics Conference on 21 July 2022. The AI ethics conference is organized by the Santa Clara University and the Markkula Center for Applied Ethics. The day-long public conference will focus on one of the most widely-debated topic in AI — Ethics.

Alpenglow Biosciences and Coreplus Partner Together to Bring 3D Spatial Biology to Clinical Research and Development

Alpenglow Biosciences (Alpenglow), developers of an innovative end-to-end 3D spatial biology platform, have announced a partnership with CorePlus, a high complexity CLIA-certified clinical and anatomic pathology laboratory, to digitize and analyze tissues in 3D to deliver novel spatial biology insights and accelerate drug development. As part of the partnership, CorePlus will invest an u********** sum into Alpenglow and receive access to Alpenglow’s 3Deep Imager, a patented hybrid open top lightsheet imaging platform.

BluWave-ai Patent Portfolio Supported by BLG LLP Launches Company into Top Global Data-Driven Technology Peer Group

Built on a comprehensive IP portfolio, BluWave-ai’s suite of grid and fleet optimization products are being used both in live networks and offline simulations worldwide. The IP portfolio is the culmination of four years of strategic research and development focusing on key areas of energy transition technology. The company patents cover state-of-the-art grid optimization, renewable energy prediction, electric vehicle fleet energy management, and real-time control systems. The resulting technology will accelerate the path to future net-zero communities, electricity system operators, and transportation networks, as large-scale adoption of solar, wind, and Electric Vehicles (EVs) transform our economies worldwide.

WellPower Partners with Natural Language Processing (NLP) Platform Augintel to Help Clinicians Save Time and Improve Clinical Outcomes

Augintel, an NLP-based SaaS platform that gives clinicians a deeper understanding of the people they care for,announced that WellPower, Denver’s community mental health provider, has selected the Augintel platform to read and process extensive amounts of case notes. The service is designed to help clinicians make well-informed decisions that will lead to improved clinical outcomes.